Three Geneva Tech Projects awarded FIF Funding
Summary
The FIF is supported by the State of Geneva, the Fondation Genevoise pour lInnovation Technologique (FONGIT), the Geneva Chamber of Commerce (CCIG), the United Nations International Trade Center (ITC) and the United Nations Environment Agency. Grant of CHF 50,000 awarded to Azure Cell Therapies Every nine minutes, a patient is diagnosed with Parkinsons disease. Seed Loan of CHF 100,000 awarded to Antion Biosciences University of Geneva spinoff Antion Biosciences has been awarded a CHF 100,000 Seed Loan to support their cutting-edge proprietary gene engineering technologies. Headed by CEO Marco Alessandrini, PhD in Biochemistry and CFO G\xe9rald Thom\xe9, MBA, Antion Biosciences focuses on making advanced cell and gene therapies safe and widely accessible for treating complex diseases. Entrepreneurs may learn more and apply here .Image: Dr. Bilal Fares, PhD-MBA, CEO and Co-Founder of Azure Cell Therapies